Safety & Efficacy of Encapsulated Allogeneic FVIII Cell Therapy in Haemophilia A
Clinical trial NCT04541628 · TERMINATED
Trial details
- NCT number
- NCT04541628
- Sponsor
- Eli Lilly and Company
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-28
- Primary completion
- 2022-10-28
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.